jump to navigation

Israel Life Science M&As and IPOs totaled $736 million in 2006 May 17, 2007

Posted by israelhealthcare in Life Science.
Tags: , ,
trackback

The number of Mergers & Acquisitions (M&As) and IPOs of Israeli life sciences companies totaled $736 million in 2006. This amount accounts for 7.4% of total M&As carried out by Israeli technology companies in 2006. According to a new survey held by IVC Research Center towards the Biomed Israel 2007 Week.

Nine life science companies raised $85 million in IPOs carried out in stock exchanges in the USA, Europe, Asia and Israel, which accounts for 12.3% of the IPOs of all high tech companies in Israel. 41% of the IPOs of life science companies were of medical instrumentation companies. The survey also reveals that 77 new life science companies were established from the beginning of 2006.

“2007 figures testify for an increase in the scope of IPOs by life science companies as compared with 2006, said Efrat Zakai, IVC’s research manager. ”From the beginning of the year, companies issued shares at total value of $145 million. The three most prominent IPOs were of BioLineRX and Itamar Medical, which were issued at the Tel Aviv Stock Exchange, and Rosetta Genomics, which was issued at NASDAQ at $30.2 million.”

Sponsored Links – Medical Compression Device | Olive Oil Baby Skin Care

Advertisements

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: